Durham, NC – According to filings with the U.S. Securities and Exchange Commission, Cell Microsystems is raising $12,666,875.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Gary Pace played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Cell Microsystems
Cell Microsystems is an early growth stage company that develops, manufactures, and markets innovative products for single cell biology. The Companys proprietary CellRaft Technology enables high-efficiency sorting and isolation of single cells under standard culture conditions resulting in unperturbed phenotypes and high viability. Coupled with the Companys automated imaging platform, a user can select a cell in real-time and track and trace that cell through imaging, collection and downstream analysis. By sorting during real-time imaging, no cells are wasted enabling single cell isolation from even small, precious samples. The CellRaft Technology offers scalable solutions making cell separation technology available for every lab.

To learn more about Cell Microsystems, visit http://cellmicrosystems.com/

Contact:
Gary Pace, President and Chief Executive Officer
252-285-9842
gpace@cellmicrosystems.com
https://www.linkedin.com/in/gary-pace-954aaa2b/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved